Report Detail
Global Biologics CDMO Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4626661 |
- 10 September, 2025 |
- Global |
- 102 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Biologics CDMO market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Biologics CDMO market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biologics CDMO market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Biologics CDMO market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Biologics CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Biologics CDMO market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biologics CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biologics CDMO market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Group AG, Samsung Biologics, AbbVie, WuXi Biologics, Toyobo, AGC, Thermo Fisher Scientific, ICON Plc, Boehringer Ingelheim, Fujifilm Diosynth Biotechnologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Biologics CDMO market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Biological Agent
Biosimilar Drug
Market segment by Application
Cell Therapy
Drug Development
Others
Major players covered
Lonza Group AG
Samsung Biologics
AbbVie
WuXi Biologics
Toyobo
AGC
Thermo Fisher Scientific
ICON Plc
Boehringer Ingelheim
Fujifilm Diosynth Biotechnologies
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biologics CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biologics CDMO, with price, sales quantity, revenue, and global market share of Biologics CDMO from 2020 to 2025.
Chapter 3, the Biologics CDMO competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologics CDMO breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Biologics CDMO market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biologics CDMO.
Chapter 14 and 15, to describe Biologics CDMO sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Biologics CDMO Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Biological Agent
- 1.3.3 Biosimilar Drug
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Biologics CDMO Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Cell Therapy
- 1.4.3 Drug Development
- 1.4.4 Others
- 1.5 Global Biologics CDMO Market Size & Forecast
- 1.5.1 Global Biologics CDMO Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Biologics CDMO Sales Quantity (2020-2031)
- 1.5.3 Global Biologics CDMO Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Lonza Group AG
- 2.1.1 Lonza Group AG Details
- 2.1.2 Lonza Group AG Major Business
- 2.1.3 Lonza Group AG Biologics CDMO Product and Services
- 2.1.4 Lonza Group AG Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Lonza Group AG Recent Developments/Updates
- 2.2 Samsung Biologics
- 2.2.1 Samsung Biologics Details
- 2.2.2 Samsung Biologics Major Business
- 2.2.3 Samsung Biologics Biologics CDMO Product and Services
- 2.2.4 Samsung Biologics Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Samsung Biologics Recent Developments/Updates
- 2.3 AbbVie
- 2.3.1 AbbVie Details
- 2.3.2 AbbVie Major Business
- 2.3.3 AbbVie Biologics CDMO Product and Services
- 2.3.4 AbbVie Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 AbbVie Recent Developments/Updates
- 2.4 WuXi Biologics
- 2.4.1 WuXi Biologics Details
- 2.4.2 WuXi Biologics Major Business
- 2.4.3 WuXi Biologics Biologics CDMO Product and Services
- 2.4.4 WuXi Biologics Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 WuXi Biologics Recent Developments/Updates
- 2.5 Toyobo
- 2.5.1 Toyobo Details
- 2.5.2 Toyobo Major Business
- 2.5.3 Toyobo Biologics CDMO Product and Services
- 2.5.4 Toyobo Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Toyobo Recent Developments/Updates
- 2.6 AGC
- 2.6.1 AGC Details
- 2.6.2 AGC Major Business
- 2.6.3 AGC Biologics CDMO Product and Services
- 2.6.4 AGC Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 AGC Recent Developments/Updates
- 2.7 Thermo Fisher Scientific
- 2.7.1 Thermo Fisher Scientific Details
- 2.7.2 Thermo Fisher Scientific Major Business
- 2.7.3 Thermo Fisher Scientific Biologics CDMO Product and Services
- 2.7.4 Thermo Fisher Scientific Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Thermo Fisher Scientific Recent Developments/Updates
- 2.8 ICON Plc
- 2.8.1 ICON Plc Details
- 2.8.2 ICON Plc Major Business
- 2.8.3 ICON Plc Biologics CDMO Product and Services
- 2.8.4 ICON Plc Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 ICON Plc Recent Developments/Updates
- 2.9 Boehringer Ingelheim
- 2.9.1 Boehringer Ingelheim Details
- 2.9.2 Boehringer Ingelheim Major Business
- 2.9.3 Boehringer Ingelheim Biologics CDMO Product and Services
- 2.9.4 Boehringer Ingelheim Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 Boehringer Ingelheim Recent Developments/Updates
- 2.10 Fujifilm Diosynth Biotechnologies
- 2.10.1 Fujifilm Diosynth Biotechnologies Details
- 2.10.2 Fujifilm Diosynth Biotechnologies Major Business
- 2.10.3 Fujifilm Diosynth Biotechnologies Biologics CDMO Product and Services
- 2.10.4 Fujifilm Diosynth Biotechnologies Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.10.5 Fujifilm Diosynth Biotechnologies Recent Developments/Updates
3 Competitive Environment: Biologics CDMO by Manufacturer
- 3.1 Global Biologics CDMO Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Biologics CDMO Revenue by Manufacturer (2020-2025)
- 3.3 Global Biologics CDMO Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Biologics CDMO by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Biologics CDMO Manufacturer Market Share in 2024
- 3.4.3 Top 6 Biologics CDMO Manufacturer Market Share in 2024
- 3.5 Biologics CDMO Market: Overall Company Footprint Analysis
- 3.5.1 Biologics CDMO Market: Region Footprint
- 3.5.2 Biologics CDMO Market: Company Product Type Footprint
- 3.5.3 Biologics CDMO Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Biologics CDMO Market Size by Region
- 4.1.1 Global Biologics CDMO Sales Quantity by Region (2020-2031)
- 4.1.2 Global Biologics CDMO Consumption Value by Region (2020-2031)
- 4.1.3 Global Biologics CDMO Average Price by Region (2020-2031)
- 4.2 North America Biologics CDMO Consumption Value (2020-2031)
- 4.3 Europe Biologics CDMO Consumption Value (2020-2031)
- 4.4 Asia-Pacific Biologics CDMO Consumption Value (2020-2031)
- 4.5 South America Biologics CDMO Consumption Value (2020-2031)
- 4.6 Middle East & Africa Biologics CDMO Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Biologics CDMO Sales Quantity by Type (2020-2031)
- 5.2 Global Biologics CDMO Consumption Value by Type (2020-2031)
- 5.3 Global Biologics CDMO Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Biologics CDMO Sales Quantity by Application (2020-2031)
- 6.2 Global Biologics CDMO Consumption Value by Application (2020-2031)
- 6.3 Global Biologics CDMO Average Price by Application (2020-2031)
7 North America
- 7.1 North America Biologics CDMO Sales Quantity by Type (2020-2031)
- 7.2 North America Biologics CDMO Sales Quantity by Application (2020-2031)
- 7.3 North America Biologics CDMO Market Size by Country
- 7.3.1 North America Biologics CDMO Sales Quantity by Country (2020-2031)
- 7.3.2 North America Biologics CDMO Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Biologics CDMO Sales Quantity by Type (2020-2031)
- 8.2 Europe Biologics CDMO Sales Quantity by Application (2020-2031)
- 8.3 Europe Biologics CDMO Market Size by Country
- 8.3.1 Europe Biologics CDMO Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Biologics CDMO Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Biologics CDMO Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Biologics CDMO Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Biologics CDMO Market Size by Region
- 9.3.1 Asia-Pacific Biologics CDMO Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Biologics CDMO Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Biologics CDMO Sales Quantity by Type (2020-2031)
- 10.2 South America Biologics CDMO Sales Quantity by Application (2020-2031)
- 10.3 South America Biologics CDMO Market Size by Country
- 10.3.1 South America Biologics CDMO Sales Quantity by Country (2020-2031)
- 10.3.2 South America Biologics CDMO Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Biologics CDMO Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Biologics CDMO Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Biologics CDMO Market Size by Country
- 11.3.1 Middle East & Africa Biologics CDMO Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Biologics CDMO Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Biologics CDMO Market Drivers
- 12.2 Biologics CDMO Market Restraints
- 12.3 Biologics CDMO Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Biologics CDMO and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Biologics CDMO
- 13.3 Biologics CDMO Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Biologics CDMO Typical Distributors
- 14.3 Biologics CDMO Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Biologics CDMO. Industry analysis & Market Report on Biologics CDMO is a syndicated market report, published as Global Biologics CDMO Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Biologics CDMO market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
